Zolgensma hits the ground running, says NovartisNovartis’ Zolgensma gene therapy for spinal muscular atrophy is the most expensive drug in the world, but that Share XZolgensma hits the ground running, says Novartishttps://pharmaphorum.com/news/zolgensma-hits-the-ground-running-says-novartis/
Federal opioid trial averted by last-ditch settlementTeva and three pharma wholesalers have agreed a $260 million settlement with two Ohio counties over their role Share XFederal opioid trial averted by last-ditch settlementhttps://pharmaphorum.com/news/federal-opioid-trial-averted-by-last-ditch-settlement/
Hall & Partners appoints Stacy Vaughn to senior US health roleHall & Partners Health has appointed Stacy Vaughn as managing partner of its US healthcare team, one of Share XHall & Partners appoints Stacy Vaughn to senior US health rolehttps://pharmaphorum.com/news/hall-partners-stacy-vaughn-beth-stagg/
Expect more M&A as Gilead names Dickinson as finance chief, say analystsGilead Sciences has named head of corporate development and strategy Andrew Dickinson as its new chief financial officer Share XExpect more M&A as Gilead names Dickinson as finance chief, say analystshttps://pharmaphorum.com/news/expect-more-ma-as-gilead-names-dickinson-as-finance-chief-say-analysts/
W2O acquires med comms agency Arcus MedicaHealthcare marketing communications agency W2O has acquired Philadelphia’s Arcus Medica to boost its scientific and med comms offering. Share XW2O acquires med comms agency Arcus Medicahttps://pharmaphorum.com/news/w2o-med-comms-agency-arcus-medica/
Guido Körfer and Marc Henschel join McCann Health GermanyPictured from left: Guido Körfer, Effie Baoutis and Marc Henschel McCann Health Germany has made two key appointments Share XGuido Körfer and Marc Henschel join McCann Health Germanyhttps://pharmaphorum.com/news/korfer-henschel-mccann-health-germany/
Alexion stalks rare disease drug from Stealth with $30m opt-in dealAlexion has taken an option on a rare disease drug from Stealth Therapeutics in late-stage development, bolstering its Share XAlexion stalks rare disease drug from Stealth with $30m opt-in dealhttps://pharmaphorum.com/news/alexion-stalks-rare-disease-drug-from-stealth-with-30m-opt-in-deal/
Football-themed film launched for World Mental Health dayA new film that tackles mental health and social media from the perspective of football influencers has been Share XFootball-themed film launched for World Mental Health dayhttps://pharmaphorum.com/news/streaming-well-healthware-football-mental-health-film/
Humira tops list of drugs with unwarranted US price hikesAbbVie’s Humira heads a list of seven medicines that collectively contributed to a $5.1 billion increase in US Share XHumira tops list of drugs with unwarranted US price hikeshttps://pharmaphorum.com/news/humira-tops-list-of-drugs-with-unwarranted-us-price-hikes/
